Multicenter Analysis of Gestational Trophoblastic Neoplasia in Turkey

Basit Öğe Kaydı
dc.authoridKULAKSIZ, DENIZ/0000-0003-2351-1367
dc.authoridKefeli, Mehmet/0000-0003-3437-5348
dc.authoridDOGAN, SELEN/0009-0003-6166-0942
dc.authoridÖzgü, Emre/0000-0002-8444-9694
dc.authoridDemirkıran, Fuat/0000-0002-0439-2502
dc.authoridtelli, elçin üzmez/0000-0002-3228-8809
dc.authoridKurdoglu, Zehra/0000-0001-5191-1072
dc.authorwosidBoran, Nurettın/AAA-2521-2020
dc.authorwosidTuran, Ahmet Taner/HJZ-4519-2023
dc.authorwosidKULAKSIZ, DENIZ/AFD-8547-2022
dc.authorwosidKefeli, Mehmet/JUU-8095-2023
dc.authorwosidDOGAN, SELEN/JAC-0863-2023
dc.authorwosidÖzgü, Emre/A-9194-2014
dc.authorwosidDemirkıran, Fuat/AAR-5596-2021
dc.contributor.authorOzalp, Sabit Sinan
dc.contributor.authorTelli, Elcin
dc.contributor.authorOge, Tufan
dc.contributor.authorTulunay, Gokhan
dc.contributor.authorBoran, Nurettin
dc.contributor.authorTuran, Taner
dc.contributor.authorYenen, Mufit
dc.date.accessioned2024-06-12T11:02:37Z
dc.date.available2024-06-12T11:02:37Z
dc.date.issued2014
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground: To evaluate the incidence, diagnosis and management of GTN among 28 centers in Turkey. Materials and Methods: A retrospective study was designed to include GTN patients attending 28 centers in the 10-year period between January 2003 and May 2013. Demographical characteristics of the patients, histopathological diagnosis, the International Federation of Gynecology and Obstetrics (FIGO) anatomical and prognostic scores, use of single-agent and multi-agent chemotherapy, surgical interventions and prognosis were evaluated. Results: From 2003-2013, there were 1,173,235 deliveries and 456 GTN cases at the 28 centers. The incidence was calculated to be 0.38 per 1,000 deliveries. According to the evaluated data of 364 patients, the median age at diagnosis was 31 years (range, 15-59 years). A histopathological diagnosis was present for 45.1% of the patients, and invasive mole, choriocarcinoma and PSTTs were diagnosed in 22.3% (n=81), 18.1% (n=66) and 4.7% (n=17) of the patients, respectively. Regarding final prognosis, 352 (96.7%) of the patients had remission, and 7 (1.9%) had persistence, whereas the disease was mortal for 5 (1.4%) of the patients. Conclusions: Because of the differences between countries, it is important to provide national registration systems and special clinics for the accurate diagnosis and treatment of GTN.en_US
dc.identifier.doi10.7314/APJCP.2014.15.8.3625
dc.identifier.endpage3628en_US
dc.identifier.issn1513-7368
dc.identifier.issue8en_US
dc.identifier.pmid24870768en_US
dc.identifier.scopus2-s2.0-84901989944en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage3625en_US
dc.identifier.urihttps://doi.org/10.7314/APJCP.2014.15.8.3625
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21358
dc.identifier.volume15en_US
dc.identifier.wosWOS:000338633500049en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAsian Pacific Organization Cancer Preventionen_US
dc.relation.ispartofAsian Pacific Journal Of Cancer Preventionen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGestational Trophoblastic Diseaseen_US
dc.subjectGestational Trophoblastic Neoplasiaen_US
dc.subjectIncidenceen_US
dc.subjectTurkeyen_US
dc.subjectManagementen_US
dc.subjectDiseasesen_US
dc.subjectChemotherapyen_US
dc.titleMulticenter Analysis of Gestational Trophoblastic Neoplasia in Turkeyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu